Stateside's Canadian Microcap Board Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Stateside's Canadian Microcap Board

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dave@SI who wrote (1527)	3/29/2016 10:28:14 AM
From: ayeyou	of 1728

There may have been some discrepancy as to who made this discovery or perhaps over the gene markers importance. Fact is he is gone stock is up and moving forward. That would suggest he was not a good fit. In the meanwhile this is very exciting news that BCT has the potential to prescreen applicants to its trial and have the trial come off a resounding success. Not very often you get head start like that in a drug trial ! Very nice work by BCT to pick up on this gene marker and very promising going into a larger scale trial. This is without a doubt why that trial has not moved ahead as scheduled. They would be stupid not to use this info in the trial selection phase. Market seems to like the news up 138% and traded 3 mil shares already 60 minutes in.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next